Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.

Monti, Sara; Montecucco, Carlomaurizio

Monti, Sara; Montecucco, Carlomaurizio.

Monti S; Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy sara.saramonti@gmail.com.
Montecucco C; Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy.

Ann Rheum Dis ; 79(6): e62, 2020 06.

Article in English | MEDLINE | ID: covidwho-1556702

Subject(s)

Antirheumatic Agents; Rheumatic Diseases; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2

Keywords

antirheumatic agents; hydroxychloroquine; lupus erythematosus, systemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatic Diseases / Antirheumatic Agents Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-217524

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google